Q
QuantAbundance

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

31,135 signal articles · 167 in last 24h · 159,358 total before filter · latest 1h ago
167last 24h
895last 7d
126● bullish (7d)
86● bearish (7d)
214publishers
AllMacro191Earnings193M&A94Regulatory16Product18Analyst29
✕ clear all filterssentiment: bearishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Elevance Stock Falls on Medicaid Concerns
The Wall Street Journal77d agobearish
Elevance Stock Falls on Medicaid Concerns

Skittish investors pushed Elevance shares down, as they focused on worries about its Medicaid business. CEO Gail Boudreaux said the insurer’s Medicaid results were roughly what it expected, but the company is leaving the District of Columbia’s Medicaid market and plans to exit others over the next year to 18 months.

Has Circle Internet Group (CRCL) Fallen Enough To Justify A Premium?
Simply Wall St.77d agobearish
Has Circle Internet Group (CRCL) Fallen Enough To Justify A Premium?

Circle Internet Group has been under pressure, with the stock down 67.6% over the past year, and the current valuation checks point to a company that does not screen as a clear bargain despite recent regulatory wins and business developments. Over the last 12 months, Circle Internet Group shares have fallen 67.6%. This sets the bar low for any case that the current price already reflects the risks. Regulatory approvals such as the OCC trust bank charter and MiCA compliance can support...

SK Hynix Drops 5%, SanDisk Slides 6%, Western Digital Slips 4% as Traders Take Profits in Memory Stocks
24/7 Wall St.77d agobearish
SK Hynix Drops 5%, SanDisk Slides 6%, Western Digital Slips 4% as Traders Take Profits in Memory Stocks

Memory stocks are pulling back sharply Wednesday morning as traders lock in gains after a parabolic run. SK Hynix‘s (NASDAQ:SKHY) U.S.-listed ADR is down 5% to $184.50 in early trading, giving back a chunk of yesterday’s 27% surge to $193.92. The reversal is rippling through the group. Micron Technology (NASDAQ:MU) shares are off 3% to ... SK Hynix Drops 5%, SanDisk Slides 6%, Western Digital Slips 4% as Traders Take Profits in Memory Stocks

Investing.com77d agobearish
Huang says Vera Rubin in production, dismisses delay reports

The denial of a delay is notable. Any credible delay in Vera Rubin's ramp would sharpen competitive pressure from AMD's advancing MI350 and MI400 roadmap, making the CEO's on-record rebuttal particularly consequential for investors who have priced Nvidia's product cycle into its elevated valuation.

Ford Should Stop Selling EVs
24/7 Wall St.77d agobearish
Ford Should Stop Selling EVs

Two bombshell reports from the Times and the Wall Street Journal suggest the American auto industry is running out of time, yet the real threat to Ford may not be Chinese EVs at all.

General Motors (GM) Missed The Hybrid Shift As Toyota Closes In
Simply Wall St.77d agobearish
General Motors (GM) Missed The Hybrid Shift As Toyota Closes In

General Motors (NYSE:GM) is losing U.S. market share in the growing hybrid vehicle segment due to limited fuel-efficient offerings. Toyota is on track to overtake GM as the top-selling U.S. automaker by year-end, marking a potential shift in industry leadership. GM now plans to reintroduce plug-in hybrids in North America by 2027 after previously stepping away from this market. General Motors sits at the center of a major reshuffle in the U.S. auto industry as hybrid vehicle sales gain...

Celcuity shares fall as delayed breast cancer drug launch eclipses first US FDA approval
Reuters77d agobearish
Celcuity shares fall as delayed breast cancer drug launch eclipses first US FDA approval

July 15 () - Shares of Celcuity fell about 8% in premarket trading on Wednesday, as the delayed commercial launch ‌of its newly approved breast cancer drug and treatment-tolerability ‌concerns overshadowed the company's first U. Food and Drug Administration on ​Tuesday approved gedatolisib, branded as Revtorpyk, for certain patients with advanced breast cancer whose tumors do not carry a PIK3CA mutation.

Cramer Pushes Back on Apple’s Sell Call — Here’s Why Investors Should Care
24/7 Wall St.77d agobearish
Cramer Pushes Back on Apple’s Sell Call — Here’s Why Investors Should Care

Shares of Apple (NASDAQ:AAPL) were stopped in their tracks when KeyBanc’s Brandon Nispel issued a downgrade to underweight from equal weight, citing valuation concerns. Indeed, it’s been quite a run for shares of Apple in recent months. They’ve quietly become a Mag Seven top performer of sorts. But before you take profits over Nispel’s sell-equivalent ... Cramer Pushes Back on Apple’s Sell Call — Here’s Why Investors Should Care

SpaceX Stock Is in a Bear Market. This Can Turn It Around.
Barrons.com77d agobearish
SpaceX Stock Is in a Bear Market. This Can Turn It Around.

SpaceX stock is dangerously close to breaking its $135 IPO price. SpaceX is set to test its huge, fully-reusable Starship for the thirteenth time. Starship promises to dramatically lower the cost of reaching space while dramatically increasing SpaceX’s capacity to put things into orbit.